As on April 05, 2021, Vivos Therapeutics Inc. (NASDAQ: VVOS) got off with the flyer as it spiked 27.21% to $9.35. During the day, the stock rose to $10.10 and sunk to $8.17 before settling in for the price of $7.35 at the close. Taking a more long-term approach, VVOS posted a 52-week range of $5.64-$14.41.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -5.70%. This publicly-traded company’s shares outstanding now amounts to $18.21 million, simultaneously with a float of $12.55 million. The organization now has a market capitalization sitting at $153.81 million. At the time of writing, stock’s 50-day Moving Average stood at $7.23.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 93 workers. It has generated 133,329 per worker during the last fiscal year. Meanwhile, its income per employee was -159,739. The stock had 10.57 Receivables turnover and 0.79 Total Asset turnover. For the Profitability, stocks gross margin was +74.20, operating margin was -66.65 and Pretax Margin of -92.28.
Vivos Therapeutics Inc. (VVOS) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Devices industry. Vivos Therapeutics Inc.’s current insider ownership accounts for 32.80%, in contrast to 4.00% institutional ownership. According to the most recent insider trade that took place on Dec 24, this organization’s Chief Financial Officer bought 1,000 shares at the rate of 7.38, making the entire transaction reach 7,380 in total value, affecting insider ownership by 1,000. Preceding that transaction, on Dec 23, Company’s Chief Executive Officer bought 1,000 for 7.27, making the whole transaction’s value amount to 7,267. This particular insider is now the holder of 1,500 in total.
Vivos Therapeutics Inc. (VVOS) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 12/30/2020, the company posted -$0.88 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.16) by -$0.72. This company achieved a net margin of -119.81 while generating a return on equity of -204.75. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
Vivos Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -5.70% and is forecasted to reach -0.61 in the upcoming year.
Vivos Therapeutics Inc. (NASDAQ: VVOS) Trading Performance Indicators
Let’s observe the current performance indicators for Vivos Therapeutics Inc. (VVOS). It’s Quick Ratio in the last reported quarter now stands at 2.60. The Stock has managed to achieve an average true range (ATR) of 0.80. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 11.74.
In the same vein, VVOS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.66, a figure that is expected to reach -0.17 in the next quarter, and analysts are predicting that it will be -0.61 at the market close of one year from today.
Technical Analysis of Vivos Therapeutics Inc. (VVOS)
Through scrutinizing the latest numbers posted by the [Vivos Therapeutics Inc., VVOS], it can be observed that its last 5-days Average volume of 0.6 million was better the volume of 0.2 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 66.09% While, its Average True Range was 0.88.